Advances in the Recognition and Management of Tenosynovial Giant Cell Tumor: A Game On! Challenge

Upon successful completion of this activity, participants should be better able to:

-Describe the clinical symptomology of TGCT as well as distinguishing features to help differentiate TGCT subtypes from related tumor types.
-Summarize factors that can be used to identify patients with TGCT who are likely versus unlikely to benefit from surgery.
-Assess the latest clinical data regarding the safety and efficacy of available and emerging targeted therapies for the nonsurgical management of TGCT.
-Outline approaches to optimize multidisciplinary care coordination in the management of patients with TGCT.

Cost: Free

View Offer chevron_right

Key Features

  • Free
  • 0.5 AMA PRA Category 1 Credit(s)™
  • 43% of activities take less than 30 minutes to complete
  • The My Healio CME Dashboard keeps track of earned credits and saved activities
  • Personalized recommendations make finding your next activity easy
  • Over 50,000 of your colleagues know that earn credits is faster and easier with Healio CME

Topics Covered

  • Tenosynovial Giant Cell Tumor (TGCT)
  • Tumors; Surgical management
  • Nonsurgical management
  • Hematology
  • Oncology

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

-Describe the clinical symptomology of TGCT as well as distinguishing features to help differentiate TGCT subtypes from related tumor types.
-Summarize factors that can be used to identify patients with TGCT who are likely versus unlikely to benefit from surgery.
-Assess the latest clinical data regarding the safety and efficacy of available and emerging targeted therapies for the nonsurgical management of TGCT.
-Outline approaches to optimize multidisciplinary care coordination in the management of patients with TGCT.

Target Audience

The intended audience for this activity is hematologist-oncologists, oncologists, orthopedic surgeons, and other health care professionals involved in the management of patients with tenosynovial giant cell tumor (TGCT).

Additional credit info

This continuing education activity is provided by Vindico Medical Education

Support Statement
This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, November 30, 2020 through November 29, 2021.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.